WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce compulsive thinking and support addiction treatment.



Chapters:

00:00 Intro
00:05 How did you get involved as a researcher in studying psychedelics?
01:24 Some people say that psychedelics are one of the first new major innovations since the 70s in Psychiatry. How do you see that?
03:07 Psychedelic treatment is a hybrid between talking therapy and psychopharmacological treatment. How is it different from traditional forms of treatment?
05:53 What is the neuro biological mechanism that explains why psychedelics are so effective in treatment?
10:16 Psychedelics don't work for everyone. Do we have any idea for whom they work and for whom they don't work?
13:45 Do psychedelics have a potential to treat addiction?
16:05 Clinical treatment has very strict rules and limitations. But people have been using psychedelics in other non-medical settings in groups, in the nature. Do you think that we can combine those methods with clinical treatment?
17:53 Some people say that we move too fast. And, there is, risk of, backlash. How do you see that risk?
18:55 You talked about retreats. As far as I know there are many retreats in the Netherlands. How are they regulated?
20:48 What is the situation with MDMA treatment in the Netherlands?
22:06 The costs of psychedelic treatment are very high. How can we make sure that they are accessible to less wealthy people as well?
24:20 How do you see the role of harm reduction in the psychedelic field?
26:09 How do you see the future of psychedelics? Will they be part of the mainstream medical care? And do they have room outside of the medical realm?

Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(123)

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

At ICPR 2024, we talked to Robert Jesse, from the Johns Hopkins University, about mystical experiences with psychedelics, their spiritual and cultural dimensions, and the value of community in support...

18 Syys 27min

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

At ICPR 2024, we talked to Leonie Schneider and Ian Roullier, co-founders and co-directors of the Psychedelic Participant Advocacy Network (PsyPAN) in the UK, about why patient voices matter in the de...

18 Syys 21min

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelic research in the Czech Republic has a long and distinguished history. At ICPR 2026, we spoke with psychiatrist and neuroscientist Tomáš Páleníček about clinical research, altered states of ...

18 Syys 26min

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researc...

31 Elo 33min

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

At ICPR 2024, we talked to anthropologist and author Nicolas Langlitz about the current hype around psychedelics, their place in medicine and culture, and why he sees them as holding the promise of mo...

31 Elo 29min

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Women make up more than half of the population, yet they remain significantly underrepresented in psychedelic research. At ICPR 2026, we spoke with neuroscientist Grace Blest-Hopley about the gender g...

31 Elo 31min

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Touko 16min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
vallattomat
aikalisa
politiikan-puskaradio
rss-viihde-media
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
rss-vaalirankkurit-podcast
rss-voi-venaja
tervo-halme
rss-raha-talous-ja-politiikka
otetaan-yhdet
rss-asiastudio
rikosmyytit
rss-kaikki-uusiksi
et-sa-noin-voi-sanoo-esittaa
rss-ulkopoditiikkaa
rss-pinnalla
rss-seksicast
rss-50100-podcast